US EditionInnocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update - PressReach
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update - PressReach
HERZLIYA, Israel and CALGARY, AB, May 28, 2025 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan“), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its financial consolidated results for the first quarter ended March 31, 2025, and provides a corporate update on its recent activities and upcoming milestones. Key Busines…
Innocan Pharma Reports First Quarter 2025 Financial Results
HERZLIYA, Israel, and CALGARY, AB — Innocan Pharma Corporation reported its financial consolidated results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Revenues increased 15% in the first quarter of 2025 to US$7.8 million, compared to US$6.8 million in the first quarter of 2024. This increase in revenue was due to the robust sales performance of Innocan’s subsidiary, BI Sky Global Ltd. Gross Profit increase…
Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTC: INSPF) (the "Company" or "Innocan"), a pharmaceutical technology company focused on the development of innovative pharmaceutical technology, announces its consolidated financial results for the first quarter ended March 31, 2025, and provides a company update on its latest activities and future milestones.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage